Laurence Reid, SVP, Chief Business Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 20,400 shares at $80.85 ($1.6M) on 2014-02-19, disclosed to the SEC on 2014-02-20.
Scheduled sale ($1.6M) by SVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.62 | 3,079 | $242K | 14.8% |
| 2 | $80.02 | 11,465 | $917K | 56.2% |
| 3 | $80.85 | 5,456 | $441K | 27.0% |
| 4 | $81.45 | 400 | $33K | 2.0% |
| Total | $80.06 avg | 20,400 | $1.6M | 100% |
| Filing → |
| ALNY | SELL | 2014-11-19 | $907K | — | Filing → |
| ALNY | SELL | 2014-08-20 | $909K | — | Filing → |
| ALNY | SELL | 2014-05-21 | $781K | — | Filing → |